TwinEdge Bioscience is a biotechnology company dedicated to the development of digital avatars for oncology drug discovery and development.

By combining cutting-edge computational biology, artificial intelligence, and personalized medicine, TwinEdge Bioscience is transforming how new cancer therapies are developed. The company’s goal is to reduce the time and cost of oncology drug development, while increasing the accuracy and effectiveness of treatments for cancer patients worldwide.

TwinEdge Bioscience’s approach combines expertise in artificial intelligence (AI), data science, and cutting-edge biological rsearch to create highly accurate models that replicate individual patient profiles. These digital avatars can simulate the effects of new oncology drugs on human cells, providing researchers with unparalleled insight into drug behaviour and efficacy. The avatars also have the potential to bring large scale patient population data to translational and clinical decision points, offering novel and invaluable insight to drug development.